Results for tag: "Tissue Microarray"

Tissue microarrays (TMAs) are an essential tool in the field of biotechnology, particularly for the analysis of multiple tissue samples in a high-throughput manner. TMAs consist of paraffin blocks in which up to several hundred separate tissue cores are assembled in a regular pattern, allowing many samples to be analyzed simultaneously. They are primarily used in the study of cancer and in the development of targeted therapies by providing a platform for rapid immunohistochemical staining and comparison of different tissues. This technology streamlines and economizes the use of resources such as reagents and antibodies, and it also facilitates the rapid assessment of gene and protein expression in different tissue specimens. Consequently, the TMA market is integral to the advancement of both basic research and the diagnostic sector in biotechnology, supporting the discovery of new markers for disease and the assessment of prognostic and predictive factors. In the TMA market, several noteworthy companies contribute to the provision of TMA technology and services. Among these, Thermo Fisher Scientific, Agilent Technologies, and Merck KGaA offer a variety of TMA instruments and related products adapted for the needs of diverse research and clinical applications. Additionally, US Biomax and Pantomics are companies specializing in the production of pre-made TMAs, thus serving researchers who require ready-to-use tissue samples for their studies. These entities operate in a specialized niche of the life sciences market, supplying vital tools that enable advancements in disease research and diagnostic methods. Show Less Read more